Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Mbio
|
January 18, 2024
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by <i>Pseudomonas aeruginosa</i>
Nicola Farrington, Vineet Dubey, Adam Johnson, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
November 19, 2013
Determination of the safety and efficacy of therapeutic neutralization of tumor necrosis factor-α (TNF-α) using AZD9773, an anti-TNF-α immune Fab, in murine CLP sepsis
Peter Newham, Daniel Ross, Peter Ceuppens, et al.
The Lancet. Digital Health
|
November 15, 2024
Using digital health technologies to optimise antimicrobial use globally
Timothy M Rawson, Nina Zhu, Ronald Galiwango, et al.
The Journal of Antimicrobial Chemotherapy
|
September 24, 2025
Antagonistic interaction between posaconazole and olorofim in a murine model of invasive pulmonary aspergillosis
Christopher A Darlow, Nicola Farrington, Anne-Grete Märtson, et al.
Antimicrobial Agents and Chemotherapy
|
May 22, 2019
Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections
Laura McEntee, Adam Johnson, Nicola Farrington, et al.
Antimicrobial Agents and Chemotherapy
|
April 8, 2020
Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing <i>Klebsiella pneumoniae</i>
Adam Johnson, Laura McEntee, Nicola Farrington, et al.
Clinical and Translational Science
|
September 18, 2018
Ceftazidime-Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups
Jianguo Li, Mark Lovern, Michelle L Green, et al.
Nature
|
August 2, 2003
Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression
Carola A Neumann, Daniela S Krause, Christopher V Carman, et al.
Antimicrobial Agents and Chemotherapy
|
August 12, 2020
Pharmacodynamics of the Novel Metallo-β-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing <i>Enterobacteriaceae</i>
Shampa Das, Adam Johnson, Laura McEntee, et al.
The Journal of Antimicrobial Chemotherapy
|
January 13, 2025
Pharmacodynamics of NOSO-502 studied in vitro and in vivo: determination of the dominant pharmacodynamic index driver
Sanne van den Berg, Marie G L Attwood, Pippa Griffin, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Mbio
|
January 18, 2024
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by <i>Pseudomonas aeruginosa</i>
Nicola Farrington, Vineet Dubey, Adam Johnson, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
November 19, 2013
Determination of the safety and efficacy of therapeutic neutralization of tumor necrosis factor-α (TNF-α) using AZD9773, an anti-TNF-α immune Fab, in murine CLP sepsis
Peter Newham, Daniel Ross, Peter Ceuppens, et al.
The Lancet. Digital Health
|
November 15, 2024
Using digital health technologies to optimise antimicrobial use globally
Timothy M Rawson, Nina Zhu, Ronald Galiwango, et al.
The Journal of Antimicrobial Chemotherapy
|
September 24, 2025
Antagonistic interaction between posaconazole and olorofim in a murine model of invasive pulmonary aspergillosis
Christopher A Darlow, Nicola Farrington, Anne-Grete Märtson, et al.
Antimicrobial Agents and Chemotherapy
|
May 22, 2019
Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections
Laura McEntee, Adam Johnson, Nicola Farrington, et al.
Antimicrobial Agents and Chemotherapy
|
April 8, 2020
Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing <i>Klebsiella pneumoniae</i>
Adam Johnson, Laura McEntee, Nicola Farrington, et al.
Clinical and Translational Science
|
September 18, 2018
Ceftazidime-Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups
Jianguo Li, Mark Lovern, Michelle L Green, et al.
Nature
|
August 2, 2003
Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression
Carola A Neumann, Daniela S Krause, Christopher V Carman, et al.
Antimicrobial Agents and Chemotherapy
|
August 12, 2020
Pharmacodynamics of the Novel Metallo-β-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing <i>Enterobacteriaceae</i>
Shampa Das, Adam Johnson, Laura McEntee, et al.
The Journal of Antimicrobial Chemotherapy
|
January 13, 2025
Pharmacodynamics of NOSO-502 studied in vitro and in vivo: determination of the dominant pharmacodynamic index driver
Sanne van den Berg, Marie G L Attwood, Pippa Griffin, et al.
Page
of 6